Consumer drug ads: The harms that come with pitching lifestyle over information
Conflicts of interest in health care journalism. Who’s watching the watchdogs? We are. Part 1 of 3
Is STAT tone-deaf in accepting PhRMA sponsorship?
Groups push pharma agenda under the guise of patient advocacy
Sponsored content, new cholesterol drugs, and the political process
PhRMA gets defensive on eve of new “Dollars for Docs” report